PLAIO

PLAIO provides pharmaceutical planning teams with a unified workflow connecting demand, supply and production data as an alternative to spreadsheet-based planning.

PLAIO is a drug discovery company in Reykjavík, Iceland, founded in 2021. It has 1 recorded funding round, most recently a Venture Round in August 2024.

Employees
11–50
Founded
2021
Business Model
B2B
Website
plaio.com
Last Round
Venture RoundAug 2024
Rounds
1

Indexed holds 1 funding round for this company. to use credits for reveals, or explore the API.

About

PLAIO provides a planning platform designed for pharmaceutical workflows that connects demand, supply and production data. It gives pharmaceutical planning teams a connected workflow in place of managing their planning through spreadsheets. The offering emphasizes bringing these planning activities and their underlying data together in a platform designed to be simple to use.

Funding History

Data from Indexed.vcUpdated
Venture RoundFunding RoundAug 2024
EUR 4.3M

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesDrug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Drug Discovery
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Drug Discovery
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Drug Discovery
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PLAIO on Indexed.vc
<a href="https://indexed.vc/companies/plaio"><img src="https://indexed.vc/api/badge/company/plaio" alt="PLAIO on Indexed.vc" width="260" height="76" /></a>